• The Give Kids a Chance Act – Reinstates the rare pediatric priority review voucher program, also known as the Creating Hope ...
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...
ROANOKE, Va. (WDBJ) - For patients needing cataract surgery, the new Light Adjustable Lens could be a game changer when it comes to fine tuning eyesight after surgery. It’s the first and only ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...
The Federal Drug Administration last month approved Journavx, a new kind of non-addictive pain medication. Doctors say ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) ...
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The F.D.A. is making its biggest move yet to end smoking. It needs to be careful not to give rise to another public health ...
Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...